Literature DB >> 10652645

Synovial tissue analysis in rheumatoid arthritis.

B Bresnihan1, P P Tak.   

Abstract

In rheumatoid arthritis, synovial tissue is easily accessible for systematic analysis. Blind needle biopsy is a simple and safe procedure, but is restricted to smaller tissue samples. Arthroscopic biopsy is also safe but is more complicated as it allows access to most sites in the joint and provides adequate tissue for extensive laboratory investigations. Synovial tissue analysis has been successfully applied to studies of disease mechanisms, response to treatment and prognosis. The immuno-histological features in synovial tissue have consistently reflected disease status. Synovial tissue analysis has been particularly informative in the study of novel therapeutic agents.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10652645     DOI： 10.1053/berh.1999.0051

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Rheumatol        ISSN： 1521-6942            Impact factor:   4.098


  11 in total

Review 1.  Synovial biopsy in arthritis research: five years of concerted European collaboration.

Authors:  B Bresnihan; P P Tak; P Emery; L Klareskog; F Breedveld
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 2.  Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.

Authors:  T R D J Radstake; A W T van Lieshout; P L C M van Riel; W B van den Berg; G J Adema
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

3.  Real-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment.

Authors:  Danielle M Gerlag; David L Boyle; Sanna Rosengren; Tony Nash; Paul P Tak; Gary S Firestein
Journal:  Ann Rheum Dis       Date:  2006-09-19       Impact factor: 19.103

4.  Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors.

Authors:  T R D J Radstake; R van der Voort; M ten Brummelhuis; M de Waal Malefijt; M Looman; C G Figdor; W B van den Berg; P Barrera; G J Adema
Journal:  Ann Rheum Dis       Date:  2004-08-26       Impact factor: 19.103

5.  IL-32, a proinflammatory cytokine in rheumatoid arthritis.

Authors:  Leo A B Joosten; Mihai G Netea; Soo-Hyun Kim; Do-Young Yoon; Birgitte Oppers-Walgreen; Timothy R D Radstake; Pilar Barrera; Fons A J van de Loo; Charles A Dinarello; Wim B van den Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

6.  Technique of synovial biopsy of metacarpophalangeal joints using the needle arthroscope.

Authors:  Levente Gáspár; Zoltán Szekanecz; Balázs Dezso; Gyula Szegedi; Zoltán Csernátony; Kálmán Szepesi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2002-12-10       Impact factor: 4.342

7.  Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis.

Authors:  Jasper J Haringman; Marjolein Vinkenoog; Danielle M Gerlag; Tom J M Smeets; Aeilko H Zwinderman; Paul P Tak
Journal:  Arthritis Res Ther       Date:  2005-05-12       Impact factor: 5.156

Review 8.  Utility of synovial biopsy.

Authors:  Stefan Vordenbäumen; Leo Ab Joosten; Johannes Friemann; Matthias Schneider; Benedikt Ostendorf
Journal:  Arthritis Res Ther       Date:  2009-11-23       Impact factor: 5.156

9.  Quantitative biomarker analysis of synovial gene expression by real-time PCR.

Authors:  David L Boyle; Sanna Rosengren; William Bugbee; Arthur Kavanaugh; Gary S Firestein
Journal:  Arthritis Res Ther       Date:  2003-10-08       Impact factor: 5.156

Review 10.  The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

Authors:  Josef S Smolen; Daniel Aletaha; Johannes Grisar; Kurt Redlich; Günter Steiner; Oswald Wagner
Journal:  Arthritis Res Ther       Date:  2008-05-29       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.